Mylan – Recall of Valsartan-Containing Products Update
December 4, 2018 - Mylan announced a voluntary, consumer-level recall of all lots within expiry of valsartan, amlodipine/valsartan, and valsartan/HCTZ tablets due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the active pharmaceutical ingredient (API) Valsartan, USP, manufactured by Mylan Laboratories Limited.
Top